JP2022512374A5 - - Google Patents
Info
- Publication number
- JP2022512374A5 JP2022512374A5 JP2021533341A JP2021533341A JP2022512374A5 JP 2022512374 A5 JP2022512374 A5 JP 2022512374A5 JP 2021533341 A JP2021533341 A JP 2021533341A JP 2021533341 A JP2021533341 A JP 2021533341A JP 2022512374 A5 JP2022512374 A5 JP 2022512374A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18212059 | 2018-12-12 | ||
| EP18212059.2 | 2018-12-12 | ||
| PCT/EP2019/084373 WO2020120449A1 (en) | 2018-12-12 | 2019-12-10 | Substituted xanthine derivatives |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022512374A JP2022512374A (ja) | 2022-02-03 |
| JPWO2020120449A5 JPWO2020120449A5 (https=) | 2022-12-16 |
| JP2022512374A5 true JP2022512374A5 (https=) | 2022-12-16 |
| JP7408662B2 JP7408662B2 (ja) | 2024-01-05 |
Family
ID=64665183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533341A Active JP7408662B2 (ja) | 2018-12-12 | 2019-12-10 | 置換キサンタン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12291532B2 (https=) |
| EP (1) | EP3894409B1 (https=) |
| JP (1) | JP7408662B2 (https=) |
| CN (1) | CN113166150B (https=) |
| WO (1) | WO2020120449A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3894409B1 (en) * | 2018-12-12 | 2023-08-23 | Boehringer Ingelheim International GmbH | Substituted xanthine derivatives |
| KR20250141831A (ko) * | 2023-02-08 | 2025-09-29 | 상하이 인스티튜트 오브 마테리아 메디카 차이니즈 아카데미 오브 싸이언시즈 | 잔틴계 화합물 및 이의 용도 |
| WO2024236027A1 (en) * | 2023-05-18 | 2024-11-21 | Boehringer Ingelheim International Gmbh | 7-(4-chlorobenzyl)-1-(3-hydroxypropyl)-3-methyl-8-(3-(trifluoromethoxy)-phenoxy)-3,7-dihydro-1h-purine-2,6-dione for use in the treatment of borderline personality disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2899646C (en) | 2013-03-15 | 2021-08-31 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
| JP6667093B2 (ja) | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ， ＬＬＣ | ピリド［２，３−ｄ］ピリミジン−２，４（１Ｈ，３Ｈ）−ジオン誘導体 |
| GB201702160D0 (en) | 2017-02-09 | 2017-03-29 | Univ Leeds Innovations Ltd | Inhibitors for use in therapy |
| SI3652176T1 (sl) * | 2017-07-11 | 2022-04-29 | Boehringer Ingelheim International Gmbh | Substituirani ksantinski derivati |
| EP3894409B1 (en) * | 2018-12-12 | 2023-08-23 | Boehringer Ingelheim International GmbH | Substituted xanthine derivatives |
-
2019
- 2019-12-10 EP EP19820717.7A patent/EP3894409B1/en active Active
- 2019-12-10 CN CN201980081691.3A patent/CN113166150B/zh active Active
- 2019-12-10 US US17/312,831 patent/US12291532B2/en active Active
- 2019-12-10 JP JP2021533341A patent/JP7408662B2/ja active Active
- 2019-12-10 WO PCT/EP2019/084373 patent/WO2020120449A1/en not_active Ceased